StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Eli Lilly (LLY) PT Raised to $105 at Piper Jaffray Amid Streamlining
September 8, 2017 6:27 AM
Piper Jaffray raised its price target ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Eli Lilly & Co. (LLY) Presents Clinical Evidence for CYRAMZA (ramucirumab) with Phase 3 RANGE Data Demonstrating Superior Progression-Free Survival in Advanced or Metastatic Urothelial Cancer
September 11, 2017 5:57 AM
Lilly to lay off 8 percent of employees in bid to cut costs
September 7, 2017 9:44 AM
Eli Lilly & Co. (LLY) Cutting 3,500 Jobs
September 7, 2017 9:18 AM